PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)72842-X
https://www.valueinhealthjournal.com/article/S1098-3015(11)72842-X/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
1000
First Page :
A438
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72842-X&doi=10.1016/S1098-3015(11)72842-X